200 related articles for article (PubMed ID: 25187406)
1. Influence of Brucella abortus lipopolysaccharide as an adjuvant on the immunogenicity of HPV-16 L1VLP vaccine in mice.
Kianmehr Z; Soleimanjahi H; Ardestani SK; Fotouhi F; Abdoli A
Med Microbiol Immunol; 2015 Apr; 204(2):205-13. PubMed ID: 25187406
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the immune responses to the CIA06-adjuvanted human papillomavirus L1 VLP vaccine with those against the licensed HPV vaccine Cervarix™ in mice.
Han JE; Wui SR; Park SA; Lee NG; Kim KS; Cho YJ; Kim HJ; Kim HJ
Vaccine; 2012 Jun; 30(28):4127-34. PubMed ID: 22561312
[TBL] [Abstract][Full Text] [Related]
3. An effective DNA priming-protein boosting approach for the cervical cancer vaccination.
Kianmehr Z; Ardestani SK; Soleimanjahi H; Farahmand B; Abdoli A; Khatami M; Akbari K; Fotouhi F
Pathog Dis; 2015 Mar; 73(2):1-8. PubMed ID: 25722486
[TBL] [Abstract][Full Text] [Related]
4. Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2.
Tumban E; Muttil P; Escobar CA; Peabody J; Wafula D; Peabody DS; Chackerian B
Vaccine; 2015 Jun; 33(29):3346-53. PubMed ID: 26003490
[TBL] [Abstract][Full Text] [Related]
5. Induction of cross-neutralizing antibodies by sequential immunization with heterologous papillomavirus L1VLPs and its implications for HPV prophylactic vaccines.
Zhang T; Chen X; Liao G; Hu M; Xu J; Xu X
J Med Virol; 2020 Dec; 92(12):3750-3758. PubMed ID: 31994744
[TBL] [Abstract][Full Text] [Related]
6. Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice.
Hongli L; Xukui L; Ting L; Wensheng L; Lusheng S; Jin Z
Hum Vaccin Immunother; 2013 Jan; 9(1):83-9. PubMed ID: 23108357
[TBL] [Abstract][Full Text] [Related]
7. Production and Preliminary In Vivo Evaluations of a Novel in silico-designed L2-based Potential HPV Vaccine.
Negahdaripour M; Nezafat N; Heidari R; Erfani N; Hajighahramani N; Ghoshoon MB; Shoolian E; Rahbar MR; Najafipour S; Dehshahri A; Morowvat MH; Ghasemi Y
Curr Pharm Biotechnol; 2020; 21(4):316-324. PubMed ID: 31729940
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity.
Karanam B; Gambhira R; Peng S; Jagu S; Kim DJ; Ketner GW; Stern PL; Adams RJ; Roden RB
Vaccine; 2009 Feb; 27(7):1040-9. PubMed ID: 19095032
[TBL] [Abstract][Full Text] [Related]
9. IgG and IgM responses to human papillomavirus L1 virus-like particle as a function of dosing schedule and vaccine formulation.
Park MH; You JW; Kim HJ; Kim HJ
J Microbiol; 2019 Sep; 57(9):821-827. PubMed ID: 31452045
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic.
Chen Y; Liu Y; Zhang G; Wang A; Dong Z; Qi Y; Wang J; Zhao B; Li N; Jiang M
Virus Res; 2016 Jul; 220():97-103. PubMed ID: 27107614
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Brucella abortus lipopolysaccharide as an adjuvant for tuberculin PPD.
Jamalan M; Ardestani SK; Zeinali M; Mosaveri N; Mohammad Taheri M
Biologicals; 2011 Jan; 39(1):23-8. PubMed ID: 20965746
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Biological and Immunological Characterization of Lipopolysaccharides From Brucella abortus RB51 and S19.
Kianmehr Z; Kaboudanian Ardestani S; Soleimanjahi H; Fotouhi F; Alamian S; Ahmadian S
Jundishapur J Microbiol; 2015 Nov; 8(11):e24853. PubMed ID: 26862376
[TBL] [Abstract][Full Text] [Related]
13.
Shirmohammadi M; Soleimanjahi H; Kianmehr Z; Karimi H; Kaboudanian Ardestani S
Iran J Basic Med Sci; 2021 Jan; 24(1):92-97. PubMed ID: 33643576
[TBL] [Abstract][Full Text] [Related]
14. A universal virus-like particle-based vaccine for human papillomavirus: longevity of protection and role of endogenous and exogenous adjuvants.
Tumban E; Peabody J; Peabody DS; Chackerian B
Vaccine; 2013 Sep; 31(41):4647-54. PubMed ID: 23933337
[TBL] [Abstract][Full Text] [Related]
15. Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach.
Wu WH; Alkutkar T; Karanam B; Roden RB; Ketner G; Ibeanu OA
Virol J; 2015 Sep; 12():140. PubMed ID: 26362430
[TBL] [Abstract][Full Text] [Related]
16. Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes.
Jagu S; Karanam B; Wang JW; Zayed H; Weghofer M; Brendle SA; Balogh KK; Tossi KP; Roden RBS; Christensen ND
Vaccine; 2015 Oct; 33(42):5553-5563. PubMed ID: 26382603
[TBL] [Abstract][Full Text] [Related]
17. Displaying 31RG-1 peptide on the surface of HPV16 L1 by use of a human papillomavirus chimeric virus-like particle induces cross-neutralizing antibody responses in mice.
Chen X; Zhang T; Liu H; Hao Y; Liao G; Xu X
Hum Vaccin Immunother; 2018; 14(8):2025-2033. PubMed ID: 29683766
[TBL] [Abstract][Full Text] [Related]
18. Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model.
Monroy-García A; Gómez-Lim MA; Weiss-Steider B; Hernández-Montes J; Huerta-Yepez S; Rangel-Santiago JF; Santiago-Osorio E; Mora García Mde L
Arch Virol; 2014 Feb; 159(2):291-305. PubMed ID: 23990055
[TBL] [Abstract][Full Text] [Related]
19. Improved immunogenicity of tetanus toxoid by Brucella abortus S19 LPS adjuvant.
Mohammadi M; Kianmehr Z; Kaboudanian Ardestani S; Gharegozlou B
Iran J Immunol; 2014 Sep; 11(3):189-99. PubMed ID: 25266004
[TBL] [Abstract][Full Text] [Related]
20. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
